T J Humphries

Summary

Affiliation: Eisai Medical Research
Country: USA

Publications

  1. ncbi Review article: drug interactions with agents used to treat acid-related diseases
    T J Humphries
    Eisai Ltd, London, UK
    Aliment Pharmacol Ther 13:18-26. 1999
  2. ncbi Review article: rabeprazole's profile in patients with gastrointestinal diseases
    T J Humphries
    Eisai Ltd, London, UK
    Aliment Pharmacol Ther 13:25-32. 1999
  3. ncbi Mass balance study of [14C] rabeprazole following oral administration in healthy subjects
    T Setoyama
    Preclinical Development, Eisai Research Institute of Boston, Inc, 1 Corporate Drive, Andover, MA 01810, USA
    Int J Clin Pharmacol Ther 44:557-65. 2006

Collaborators

Detail Information

Publications3

  1. ncbi Review article: drug interactions with agents used to treat acid-related diseases
    T J Humphries
    Eisai Ltd, London, UK
    Aliment Pharmacol Ther 13:18-26. 1999
    ..These differences are important when choosing medications for the safe treatment of patients with acid-related diseases...
  2. ncbi Review article: rabeprazole's profile in patients with gastrointestinal diseases
    T J Humphries
    Eisai Ltd, London, UK
    Aliment Pharmacol Ther 13:25-32. 1999
    ..Rabeprazole is likely to be a valuable new addition to its class in treating patients with acid-related gastrointestinal diseases given its efficacy in acid suppression, high healing rates, rapid symptom relief, and convenient dosing...
  3. ncbi Mass balance study of [14C] rabeprazole following oral administration in healthy subjects
    T Setoyama
    Preclinical Development, Eisai Research Institute of Boston, Inc, 1 Corporate Drive, Andover, MA 01810, USA
    Int J Clin Pharmacol Ther 44:557-65. 2006
    ..14C] rabeprazole was rapidly absorbed after oral administration and mostly excreted in urine...